Literature DB >> 552555

Bromocriptine and acromegaly: therapeutic implications.

A P Brooks, P J Stephen, I M Nairn, J A Strong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 552555      PMCID： PMC1436916          DOI： 10.1177/014107687907200804

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.

Authors:  A Liuzzi; P G Chiodini; L Botalla; G Cremascoli; E E Müller; F Silvestrini
Journal:  J Clin Endocrinol Metab       Date:  1974-05       Impact factor: 5.958

2.  Long-term treatment of acromegaly with bromocriptine.

Authors:  J A Wass; M O Thorner; D V Morris; L H Rees; A S Mason; A E Jones; G M Besser
Journal:  Br Med J       Date:  1977-04-02

3.  Bromocriptine treatment of acromegaly.

Authors:  M O Thorner; A Chait; M Aitken; G Benker; S R Bloom; C H Mortimer; P Sanders; A S Mason; G M Besser
Journal:  Br Med J       Date:  1975-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.